Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Rheumatology Drugs Market Size Growth Rate by Type (2014-2025) 1.4.2 Disease Modifying Anti-rheumatic Drugs 1.4.3 Nonsteroidal Anti-inflammatory Drugs 1.4.4 Corticosteroids 1.4.5 Uric Acid Drugs 1.4.6 Others 1.5 Market by Application 1.5.1 Global Rheumatology Drugs Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Rheumatology Drugs Market Size 2.2 Rheumatology Drugs Growth Trends by Regions 2.2.1 Rheumatology Drugs Market Size by Regions (2014-2025) 2.2.2 Rheumatology Drugs Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Rheumatology Drugs Market Size by Manufacturers 3.1.1 Global Rheumatology Drugs Revenue by Manufacturers (2014-2019) 3.1.2 Global Rheumatology Drugs Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Rheumatology Drugs Key Players Head office and Area Served 3.3 Key Players Rheumatology Drugs Product/Solution/Service 3.4 Date of Enter into Rheumatology Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Rheumatology Drugs Market Size by Type (2014-2019) 4.2 Global Rheumatology Drugs Market Size by Application (2014-2019) 5 United States 5.1 United States Rheumatology Drugs Market Size (2014-2019) 5.2 Rheumatology Drugs Key Players in United States 5.3 United States Rheumatology Drugs Market Size by Type 5.4 United States Rheumatology Drugs Market Size by Application 6 Europe 6.1 Europe Rheumatology Drugs Market Size (2014-2019) 6.2 Rheumatology Drugs Key Players in Europe 6.3 Europe Rheumatology Drugs Market Size by Type 6.4 Europe Rheumatology Drugs Market Size by Application 7 China 7.1 China Rheumatology Drugs Market Size (2014-2019) 7.2 Rheumatology Drugs Key Players in China 7.3 China Rheumatology Drugs Market Size by Type 7.4 China Rheumatology Drugs Market Size by Application 8 Japan 8.1 Japan Rheumatology Drugs Market Size (2014-2019) 8.2 Rheumatology Drugs Key Players in Japan 8.3 Japan Rheumatology Drugs Market Size by Type 8.4 Japan Rheumatology Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Rheumatology Drugs Market Size (2014-2019) 9.2 Rheumatology Drugs Key Players in Southeast Asia 9.3 Southeast Asia Rheumatology Drugs Market Size by Type 9.4 Southeast Asia Rheumatology Drugs Market Size by Application 10 India 10.1 India Rheumatology Drugs Market Size (2014-2019) 10.2 Rheumatology Drugs Key Players in India 10.3 India Rheumatology Drugs Market Size by Type 10.4 India Rheumatology Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Rheumatology Drugs Market Size (2014-2019) 11.2 Rheumatology Drugs Key Players in Central & South America 11.3 Central & South America Rheumatology Drugs Market Size by Type 11.4 Central & South America Rheumatology Drugs Market Size by Application 12 International Players Profiles 12.1 Takeda Pharmaceutical 12.1.1 Takeda Pharmaceutical Company Details 12.1.2 Company Description and Business Overview 12.1.3 Rheumatology Drugs Introduction 12.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2014-2019) 12.1.5 Takeda Pharmaceutical Recent Development 12.2 Sanofi 12.2.1 Sanofi Company Details 12.2.2 Company Description and Business Overview 12.2.3 Rheumatology Drugs Introduction 12.2.4 Sanofi Revenue in Rheumatology Drugs Business (2014-2019) 12.2.5 Sanofi Recent Development 12.3 Genentech 12.3.1 Genentech Company Details 12.3.2 Company Description and Business Overview 12.3.3 Rheumatology Drugs Introduction 12.3.4 Genentech Revenue in Rheumatology Drugs Business (2014-2019) 12.3.5 Genentech Recent Development 12.4 Novartis 12.4.1 Novartis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Rheumatology Drugs Introduction 12.4.4 Novartis Revenue in Rheumatology Drugs Business (2014-2019) 12.4.5 Novartis Recent Development 12.5 Janssen Biotech 12.5.1 Janssen Biotech Company Details 12.5.2 Company Description and Business Overview 12.5.3 Rheumatology Drugs Introduction 12.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2014-2019) 12.5.5 Janssen Biotech Recent Development 12.6 Amgen 12.6.1 Amgen Company Details 12.6.2 Company Description and Business Overview 12.6.3 Rheumatology Drugs Introduction 12.6.4 Amgen Revenue in Rheumatology Drugs Business (2014-2019) 12.6.5 Amgen Recent Development 12.7 AbbVie 12.7.1 AbbVie Company Details 12.7.2 Company Description and Business Overview 12.7.3 Rheumatology Drugs Introduction 12.7.4 AbbVie Revenue in Rheumatology Drugs Business (2014-2019) 12.7.5 AbbVie Recent Development 12.8 Pfizer 12.8.1 Pfizer Company Details 12.8.2 Company Description and Business Overview 12.8.3 Rheumatology Drugs Introduction 12.8.4 Pfizer Revenue in Rheumatology Drugs Business (2014-2019) 12.8.5 Pfizer Recent Development 12.9 Bristol-Myers Squibb Company 12.9.1 Bristol-Myers Squibb Company Company Details 12.9.2 Company Description and Business Overview 12.9.3 Rheumatology Drugs Introduction 12.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2014-2019) 12.9.5 Bristol-Myers Squibb Company Recent Development 12.10 Merck & Co. 12.10.1 Merck & Co. Company Details 12.10.2 Company Description and Business Overview 12.10.3 Rheumatology Drugs Introduction 12.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2014-2019) 12.10.5 Merck & Co. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Rheumatology Drugs Key Market Segments Table Key Players Rheumatology Drugs Covered Table Global Rheumatology Drugs Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Rheumatology Drugs Market Size Market Share by Type 2014-2025 Figure Disease Modifying Anti-rheumatic Drugs Figures Table Key Players of Disease Modifying Anti-rheumatic Drugs Figure Nonsteroidal Anti-inflammatory Drugs Figures Table Key Players of Nonsteroidal Anti-inflammatory Drugs Figure Corticosteroids Figures Table Key Players of Corticosteroids Figure Uric Acid Drugs Figures Table Key Players of Uric Acid Drugs Figure Others Figures Table Key Players of Others Table Global Rheumatology Drugs Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacy Case Studies Figure Retail Pharmacy Case Studies Figure Online Pharmacy Case Studies Figure Rheumatology Drugs Report Years Considered Table Global Rheumatology Drugs Market Size 2014-2025 (Million US$) Figure Global Rheumatology Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Rheumatology Drugs Market Size by Regions 2014-2025 (Million US$) Table Global Rheumatology Drugs Market Size by Regions 2014-2019 (Million US$) Table Global Rheumatology Drugs Market Share by Regions 2014-2019 Figure Global Rheumatology Drugs Market Share by Regions 2014-2019 Figure Global Rheumatology Drugs Market Share by Regions 2019 Table Market Top Trends Table Global Rheumatology Drugs Revenue by Manufacturers (2014-2019) (Million US$) Table Global Rheumatology Drugs Market Share by Manufacturers (2014-2019) Figure Global Rheumatology Drugs Market Share by Manufacturers in 2018 Table Global Rheumatology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Rheumatology Drugs Product/Solution/Service Table Date of Enter into Rheumatology Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table Global Rheumatology Drugs Market Size Share by Type (2014-2019) Figure Global Rheumatology Drugs Market Size Market Share by Type (2014-2019) Table Global Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table Global Rheumatology Drugs Market Size Share by Application (2014-2019) Figure Global Rheumatology Drugs Market Size Market Share by Application (2014-2019) Figure Global Rheumatology Drugs Revenue Market Share by Application in 2018 Figure United States Rheumatology Drugs Market Size 2014-2019 (Million US$) Table United States Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table United States Key Players Rheumatology Drugs Market Share (2018-2019) Table United States Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table United States Rheumatology Drugs Market Share by Type (2014-2019) Table United States Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table United States Rheumatology Drugs Market Share by Application (2014-2019) Figure Europe Rheumatology Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Rheumatology Drugs Market Share (2018-2019) Table Europe Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table Europe Rheumatology Drugs Market Share by Type (2014-2019) Table Europe Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table Europe Rheumatology Drugs Market Share by Application (2014-2019) Figure China Rheumatology Drugs Market Size 2014-2019 (Million US$) Table China Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table China Key Players Rheumatology Drugs Market Share (2018-2019) Table China Rheumatology Drugs Market Size by Type (2014-20189) (Million US$) Table China Rheumatology Drugs Market Share by Type (2014-2019) Table China Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table China Rheumatology Drugs Market Share by Application (2014-2019) Figure Japan Rheumatology Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Rheumatology Drugs Market Share (2018-2019) Table Japan Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table Japan Rheumatology Drugs Market Share by Type (2014-2019) Table Japan Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table Japan Rheumatology Drugs Market Share by Application (2014-2019) Figure Southeast Asia Rheumatology Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Rheumatology Drugs Market Share (2018-2019) Table Southeast Asia Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Rheumatology Drugs Market Share by Type (2014-2019) Table Southeast Asia Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Rheumatology Drugs Market Share by Application (2014-2019) Figure India Rheumatology Drugs Market Size 2014-2019 (Million US$) Table India Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table India Key Players Rheumatology Drugs Market Share (2018-2019) Table India Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table India Rheumatology Drugs Market Share by Type (2014-2019) Table India Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table India Rheumatology Drugs Market Share by Application (2014-2019) Figure Central & South America Rheumatology Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Rheumatology Drugs Market Share (2018-2019) Table Central & South America Rheumatology Drugs Market Size by Type (2014-2019) (Million US$) Table Central & South America Rheumatology Drugs Market Share by Type (2014-2019) Table Central & South America Rheumatology Drugs Market Size by Application (2014-2019) (Million US$) Table Central & South America Rheumatology Drugs Market Share by Application (2014-2019) Table Takeda Pharmaceutical Company Details Table Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2014-2019) (Million US$) Figure Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Takeda Pharmaceutical Recent Development Table Sanofi Company Details Table Sanofi Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Sanofi Recent Development Table Genentech Company Details Table Genentech Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Genentech Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Genentech Recent Development Table Novartis Company Details Table Novartis Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Novartis Recent Development Table Janssen Biotech Company Details Table Janssen Biotech Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Janssen Biotech Recent Development Table Amgen Company Details Table Amgen Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Amgen Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Amgen Recent Development Table AbbVie Company Details Table AbbVie Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table AbbVie Recent Development Table Pfizer Company Details Table Pfizer Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Pfizer Recent Development Table Bristol-Myers Squibb Company Company Details Table Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Bristol-Myers Squibb Company Recent Development Table Merck & Co. Company Details Table Merck & Co. Revenue in Rheumatology Drugs Business (2014-2019)(Million US$) Figure Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2014-2019) Table Merck & Co. Recent Development Table Global Rheumatology Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Rheumatology Drugs Market Size Share by Regions (2019-2025) Figure Global Rheumatology Drugs Market Size Share by Regions in 2025 Figure United States Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Rheumatology Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Rheumatology Drugs Market Size by Product (2019-2025) Figure Global Rheumatology Drugs Market Size by Product in 2025 Table Global Rheumatology Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Rheumatology Drugs Market Size by Application (2019-2025) Figure Global Rheumatology Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Takeda Pharmaceutical Sanofi Genentech Novartis Janssen Biotech Amgen AbbVie Pfizer Bristol-Myers Squibb Company Merck & Co.